» Articles » PMID: 27795755

Metastatic Giant Basal Cell Carcinoma: a Case Report

Overview
Journal Pan Afr Med J
Date 2016 Nov 1
PMID 27795755
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Basal cell carcinoma is the most common skin cancer, characterised by a slow growing behavior, metastasis are extremely rare, and it occurs in less than 0, 1% of all cases. Giant basal cell carcinoma is a rare form of basal cell carcinoma, more aggressive and defined as a tumor measuring more than 5 cm at its largest diameter. Only 1% of all basal cell carcinoma develops to a giant basal cell carcinoma, resulting of patient's negligence. Giant basal cell carcinoma is associated with higher potential of metastasis and even death, compared to ordinary basal cell carcinoma. We report a case of giant basal cell carcinoma metastaticin lung occurring in a 79 years old male patient, with a fatal evolution after one course of systemic chemotherapy. Giant basal cell carcinoma is a very rare entity, early detection of these tumors could prevent metastasis occurrence and improve the prognosis of this malignancy.

Citing Articles

Electrochemotherapy for the treatment of basal cell tumours of the nasal planum in three cats.

Salmoral A, Penzo C, Baines S JFMS Open Rep. 2024; 10(1):20551169231213499.

PMID: 38322251 PMC: 10846178. DOI: 10.1177/20551169231213499.


Giant basal cell carcinoma of anterior chest wall reveals metastasis to lungs: A case report.

Ahmad S, Song D, Reyes J, Durrance R, Jaiswal V, Pokhrel N Clin Case Rep. 2022; 10(2):e05421.

PMID: 35140975 PMC: 8813667. DOI: 10.1002/ccr3.5421.


Superficial basal cell carcinoma treated with 70% trichloroacetic acid applied topically: a case study.

Chiriac A, Brzezinski P, Moldovan C, Podoleanu C, Coros M, Stolnicu S Clin Cosmet Investig Dermatol. 2017; 10:67-69.

PMID: 28260938 PMC: 5327847. DOI: 10.2147/CCID.S127040.

References
1.
Amin S, Motamedi K, Ochsner M, Song T, Hybarger C . Mechanisms and efficacy of vismodegib in the treatment of basal cell carcinoma. Discov Med. 2013; 16(89):229-32. View

2.
Lackey P, Sargent L, Wong L, Brzezienski M, Kennedy J . Giant basal cell carcinoma surgical management and reconstructive challenges. Ann Plast Surg. 2007; 58(3):250-4. DOI: 10.1097/01.sap.0000250842.96272.37. View

3.
Randle H, Roenigk R, Brodland D . Giant basal cell carcinoma (T3). Who is at risk?. Cancer. 1993; 72(5):1624-30. DOI: 10.1002/1097-0142(19930901)72:5<1624::aid-cncr2820720522>3.0.co;2-d. View

4.
Gilbody J, Aitken J, Green A . What causes basal cell carcinoma to be the commonest cancer?. Aust J Public Health. 1994; 18(2):218-21. DOI: 10.1111/j.1753-6405.1994.tb00231.x. View

5.
Zoccali G, Pajand R, Papa P, Orsini G, Lomartire N, Giuliani M . Giant basal cell carcinoma of the skin: literature review and personal experience. J Eur Acad Dermatol Venereol. 2012; 26(8):942-52. DOI: 10.1111/j.1468-3083.2011.04427.x. View